| 25 May 2026 |
BMK methyl glycidate CAS 80532-66-7 |
7.2 |
5g |
5.3g |
+5.6% |
97.00% |
Lab B |
| 25 May 2026 |
DNP |
6.9 |
10mg |
8.6mg |
-13.6% |
96.68% |
Lab F |
| 25 May 2026 |
KPV Oral |
4.0 |
25mg |
29.0mg |
+15.8% |
96.88% |
Lab F |
| 25 May 2026 |
Metribolone |
5.7 |
100mg/ml |
96.8mg/ml |
-3.2% |
96.92% |
Lab G |
| 25 May 2026 |
Proviron (Mesterolone) |
4.0 |
100mg |
90.2mg |
-9.8% |
99.54% |
Lab C |
| 25 May 2026 |
Tesofensine |
4.0 |
10mg |
9.5mg |
-5.2% |
96.35% |
Lab B |
| 24 May 2026 |
Botulinum toxin |
6.0 |
10mg |
9.7mg |
-2.8% |
97.54% |
Lab C |
| 24 May 2026 |
KPV Oral |
4.0 |
100mg |
88.6mg |
-11.4% |
96.36% |
Lab B |
| 24 May 2026 |
Sustanon 400 |
6.9 |
200mg/ml |
246.0mg/ml |
+23.0% |
97.88% |
Lab D |
| 24 May 2026 |
VIP |
5.3 |
50mg |
60.0mg |
+20.1% |
97.32% |
Lab F |
| 24 May 2026 |
Cerebrolysin |
4.0 |
50mg |
52.7mg |
+5.3% |
99.20% |
Lab D |
| 24 May 2026 |
Prostamax |
5.7 |
30mg |
33.6mg |
+11.8% |
99.64% |
Lab G |
| 24 May 2026 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
5.3 |
10g |
8.6g |
-14.4% |
96.68% |
Lab D |
| 24 May 2026 |
Boldenone Cypionate |
7.7 |
200mg/ml |
186.2mg/ml |
-6.9% |
97.64% |
Lab F |
| 24 May 2026 |
DNP |
6.0 |
10mg |
8.9mg |
-10.6% |
98.79% |
Lab F |
| 24 May 2026 |
Lipo-C FAT BLASTER |
7.0 |
300mg/ml |
299.4mg/ml |
-0.2% |
96.09% |
Lab B |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.8 |
5mg |
5.8mg |
+15.8% |
95.01% |
Lab F |
| 24 May 2026 |
MT-1 |
5.5 |
2mg |
1.8mg |
-9.7% |
95.89% |
Lab B |
| 24 May 2026 |
Proviron (Mesterolone) |
4.3 |
25mg |
22.4mg |
-10.6% |
98.12% |
Lab D |
| 24 May 2026 |
ACE-031 |
5.2 |
10mg |
12.5mg |
+24.7% |
99.72% |
Lab A |
| 24 May 2026 |
GHRP-6 Acetate |
7.6 |
10mg |
10.2mg |
+2.0% |
95.01% |
Lab B |
| 24 May 2026 |
Winstrol Oil |
4.7 |
300mg/ml |
280.5mg/ml |
-6.5% |
97.24% |
Lab F |
| 23 May 2026 |
BAC Water |
6.5 |
50mg |
57.7mg |
+15.3% |
96.07% |
Lab F |
| 23 May 2026 |
GHRP-6 Acetate |
6.2 |
2mg |
1.7mg |
-14.5% |
99.46% |
Lab E |
| 23 May 2026 |
Cortagen |
5.2 |
30mg |
31.6mg |
+5.4% |
97.30% |
Lab B |
| 23 May 2026 |
HMG |
8.5 |
5mg |
4.9mg |
-1.4% |
96.56% |
Lab A |
| 23 May 2026 |
MT-1 |
5.5 |
2mg |
2.4mg |
+17.6% |
96.00% |
Lab D |
| 21 May 2026 |
BAC Water |
6.9 |
30mg |
32.5mg |
+8.5% |
98.88% |
Lab A |
| 21 May 2026 |
Primobolan E Raw |
6.3 |
5g |
5.9g |
+17.9% |
97.30% |
Lab E |
| 21 May 2026 |
Semaglutide Oral |
4.5 |
10mg |
11.1mg |
+11.3% |
95.77% |
Lab D |
| 21 May 2026 |
Sustanon 400 |
4.0 |
100mg/ml |
104.8mg/ml |
+4.8% |
97.13% |
Lab F |
| 20 May 2026 |
YK11 |
9.9 |
25mg |
24.8mg |
-1.0% |
95.51% |
Lab E |
| 19 May 2026 |
Aromasin (Exemestane) |
6.9 |
10mg |
11.3mg |
+12.9% |
99.62% |
Lab E |
| 19 May 2026 |
Ovagen |
7.4 |
20mg |
19.6mg |
-2.0% |
99.69% |
Lab B |
| 17 May 2026 |
BAC Water |
9.1 |
2mg |
1.8mg |
-7.5% |
97.56% |
Lab F |
| 17 May 2026 |
Methylene Blue |
6.1 |
10mg |
11.2mg |
+11.6% |
98.50% |
Lab E |
| 17 May 2026 |
MOTS-C |
4.0 |
20mg |
22.7mg |
+13.7% |
96.38% |
Lab F |
| 29 Jan 2026 |
Tesofensine |
5.7 |
50mg |
45.0mg |
-10.0% |
96.75% |
Lab G |
| 26 Jan 2026 |
Nitroethane CAS 79-24-3 |
8.3 |
100g |
103.6g |
+3.6% |
97.37% |
Lab G |
| 26 Jan 2026 |
S-23 Raw |
5.5 |
500g |
584.0g |
+16.8% |
99.84% |
Lab G |
| 19 Jan 2026 |
Cortagen |
4.1 |
30mg |
35.9mg |
+19.6% |
97.20% |
Lab E |
| 19 Jan 2026 |
GW-501516 (Cardarine) |
7.5 |
10mg |
11.1mg |
+10.9% |
97.21% |
Lab D |
| 19 Jan 2026 |
HMG |
8.6 |
50mg |
57.9mg |
+15.8% |
96.24% |
Lab A |
| 19 Jan 2026 |
MOTS-C |
7.9 |
5mg |
5.0mg |
+1.0% |
98.24% |
Lab D |
| 19 Jan 2026 |
VIP |
4.0 |
15mg |
14.8mg |
-1.3% |
95.27% |
Lab F |
| 9 Jan 2026 |
Cerebrolysin |
4.0 |
30mg |
34.3mg |
+14.3% |
99.67% |
Lab B |
| 7 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
10.0 |
250mg/ml |
264.3mg/ml |
+5.7% |
95.80% |
Lab F |
| 7 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
5.6 |
300mg/ml |
313.4mg/ml |
+4.5% |
97.11% |
Lab A |
| 7 Jan 2026 |
Tren Hex |
5.6 |
100mg/ml |
109.2mg/ml |
+9.2% |
96.97% |
Lab C |
| 7 Jan 2026 |
YK11 |
6.5 |
100mg |
89.1mg |
-10.9% |
95.87% |
Lab A |
| 6 Jan 2026 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
5.4 |
5g |
4.6g |
-7.1% |
95.69% |
Lab E |
| 6 Jan 2026 |
BMK methyl glycidate CAS 80532-66-7 |
5.2 |
100g |
95.8g |
-4.2% |
95.53% |
Lab A |
| 6 Jan 2026 |
Proviron (Mesterolone) |
4.0 |
25mg |
28.3mg |
+13.3% |
96.53% |
Lab C |
| 29 Dec 2025 |
Methylene Blue |
4.9 |
10mg |
8.6mg |
-14.2% |
95.91% |
Lab D |
| 12 Dec 2025 |
Boldenone Cypionate |
5.7 |
300mg/ml |
302.4mg/ml |
+0.8% |
96.89% |
Lab E |
| 12 Dec 2025 |
GW-501516 (Cardarine) |
7.0 |
25mg |
31.2mg |
+24.6% |
99.51% |
Lab A |
| 12 Dec 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.3 |
10mg |
8.6mg |
-14.0% |
96.41% |
Lab F |
| 12 Dec 2025 |
MT-1 |
6.3 |
30mg |
34.6mg |
+15.4% |
97.86% |
Lab E |
| 12 Dec 2025 |
Ovagen |
5.7 |
20mg |
22.4mg |
+11.8% |
96.17% |
Lab D |
| 12 Dec 2025 |
Tesofensine |
6.9 |
20mg |
24.9mg |
+24.7% |
99.06% |
Lab A |
| 12 Dec 2025 |
Winstrol Oil |
5.6 |
200mg/ml |
186.8mg/ml |
-6.6% |
97.02% |
Lab E |
| 5 Dec 2025 |
ACE-031 |
6.1 |
50mg |
50.4mg |
+0.8% |
96.30% |
Lab F |
| 5 Dec 2025 |
Boldenone Cypionate |
5.4 |
200mg/ml |
218.0mg/ml |
+9.0% |
96.26% |
Lab B |
| 23 Nov 2025 |
GW-501516 (Cardarine) |
4.8 |
20mg |
18.1mg |
-9.5% |
99.25% |
Lab C |
| 23 Nov 2025 |
N-Acetyl Epitalon Amidate |
7.5 |
5mg |
4.8mg |
-3.3% |
95.04% |
Lab B |
| 17 Nov 2025 |
CJC-1295 With DAC |
8.5 |
50mg |
49.8mg |
-0.4% |
99.62% |
Lab F |
| 17 Nov 2025 |
Metribolone |
5.2 |
300mg/ml |
255.2mg/ml |
-14.9% |
96.69% |
Lab A |
| 17 Nov 2025 |
S-23 Raw |
5.5 |
100g |
87.5g |
-12.5% |
99.59% |
Lab C |
| 14 Nov 2025 |
Aromasin (Exemestane) |
8.0 |
50mg |
50.1mg |
+0.1% |
95.20% |
Lab C |
| 5 Nov 2025 |
Orforglipron |
6.6 |
100mg |
97.5mg |
-2.5% |
96.10% |
Lab E |
| 5 Nov 2025 |
Winstrol Oil |
4.5 |
100mg/ml |
88.5mg/ml |
-11.5% |
97.32% |
Lab B |
| 4 Nov 2025 |
Ovagen |
6.1 |
5mg |
5.0mg |
-0.4% |
95.14% |
Lab A |
| 4 Nov 2025 |
YK11 |
6.7 |
100mg |
119.5mg |
+19.5% |
99.33% |
Lab F |
| 17 Oct 2025 |
Equipoise (Boldenone Undecylenate) |
9.6 |
200mg/ml |
210.0mg/ml |
+5.0% |
98.09% |
Lab F |
| 17 Oct 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
5.6 |
50mg |
47.0mg |
-6.0% |
97.89% |
Lab B |
| 17 Oct 2025 |
Primobolan E Raw |
6.5 |
500g |
516.2g |
+3.2% |
95.37% |
Lab F |
| 9 Oct 2025 |
EPO |
6.0 |
30mg |
32.9mg |
+9.6% |
95.13% |
Lab B |
| 9 Oct 2025 |
S-23 Raw |
5.8 |
10g |
12.1g |
+21.4% |
96.40% |
Lab C |
| 9 Oct 2025 |
Semaglutide Oral |
6.5 |
50mg |
60.8mg |
+21.7% |
96.06% |
Lab F |
| 3 Oct 2025 |
GHRP-6 Acetate |
5.7 |
5mg |
5.1mg |
+2.3% |
97.43% |
Lab B |
| 3 Oct 2025 |
Metribolone |
6.9 |
300mg/ml |
326.9mg/ml |
+9.0% |
96.84% |
Lab G |
| 3 Oct 2025 |
Prostamax |
4.5 |
2mg |
2.0mg |
+1.1% |
98.77% |
Lab A |
| 21 May 2025 |
Tirzepatide |
|
5.5 |
10mg |
10.7mg |
+7.0% |
Black Label / Silver Crimp / Red Cap |
| 21 May 2025 |
Semaglutide |
|
5.4 |
5mg |
5.4mg |
+8.0% |
Black Label / Silver Crimp / White Cap |
| 21 May 2025 |
Retatrutide |
|
4.0 |
5mg |
5.7mg |
+14.0% |
Black Label / Silver Crimp / Green Cap |
| 20 May 2025 |
CJC-1295 |
No DAC |
6.6 |
2mg |
2.02mg |
+1.0% |
Black Label / Silver Crimp / Purple Cap |
| 20 May 2025 |
Ipamorelin |
|
1.9 |
5mg |
6.27mg |
+25.4% |
Black Label / Silver Crimp / White Cap |
| 5 May 2025 |
BPC-157 |
|
5.8 |
5mg |
5.58mg |
+11.6% |
Black Label / Silver Crimp / Red Cap |
| 2 May 2025 |
BPC-157 |
|
5.4 |
5mg |
5.21mg |
+4.2% |
Black Label / Silver Crimp / Red Cap |